Tarek El-Metwally | Non-Communicable Diseases | Innovative Research Award

Innovative Research Award

Tarek El-Metwally
Affiliation Al Jouf University
Country Saudi Arabia
Scopus ID 6507910852
Documents 45
Citations 847
h-index 16
Subject Area Non-Communicable Diseases
Event Global Diseases Research Awards
ORCID 0000-0001-9040-6642

Tarek El-Metwally is a researcher affiliated with Al Jouf University, Saudi Arabia, whose scholarly profile is associated with the field of non-communicable diseases. His indexed research record comprises 45 documents, 847 citations, and an h-index of 16, according to the supplied Scopus profile information. [1]

Abstract

Tarek El-Metwally is an academic researcher affiliated with Al Jouf University in Saudi Arabia and associated with the research area of non-communicable diseases. The supplied bibliographic profile records 45 indexed documents, 847 citations, and an h-index of 16. These indicators provide a quantitative overview of scholarly productivity and citation-based research influence. His profile is presented in connection with the Innovative Research Award under the Global Diseases Research Awards. The recognition framework highlights research activity relevant to global disease challenges while providing structured information about institutional affiliation, publication activity, scholarly visibility, and researcher identification through Scopus and ORCID. The profile does not independently establish the quality or originality of individual studies, but summarizes supplied bibliometric information for academic recognition and reference.[1]

Keywords

Innovative Research Award, Tarek El-Metwally, Al Jouf University, Saudi Arabia, non-communicable diseases, disease research, biomedical research, research impact, Scopus, ORCID, scholarly publications, research recognition, Global Diseases Research Awards.[1]

Introduction

Non-communicable diseases represent a major area of global health research and include conditions requiring sustained investigation across epidemiology, prevention, diagnosis, treatment, and health systems. Research in this field increasingly depends on multidisciplinary evidence and internationally visible scholarly communication. The present profile situates Tarek El-Metwally within this broader research context.[1]

Research Profile

The supplied research profile identifies Tarek El-Metwally with Al Jouf University in Saudi Arabia and assigns Scopus Author ID 6507910852. The record contains 45 documents, 847 citations, and an h-index of 16. These bibliometric measures are commonly used to describe publication output and citation visibility within indexed scholarly literature. [4]

Research Contributions

The available profile information supports an assessment of sustained scholarly participation in non-communicable disease research. A record of 45 documents indicates continuing publication activity, while 847 citations demonstrate that the indexed publications have received measurable scholarly attention. Interpretation of individual contributions requires examination of the underlying publications and their research methodologies..[3]

Publications

The Scopus profile supplied for Tarek El-Metwally records 45 documents associated with the researcher identifier 6507910852. These documents form the bibliographic basis for the reported citation and h-index indicators. A complete publication-level assessment would require reviewing individual article titles, journals, publication years, co-authorship patterns, subject classifications, and citation records. [2]

Research Impact

The reported 847 citations and h-index of 16 provide quantitative indicators of the visibility of the researcher’s indexed scholarly output. Citation measures should be interpreted within disciplinary and career-stage contexts because citation practices vary across fields. They are useful descriptive indicators, but they should not be considered a complete measure of research quality or societal impact. [1]

Award Suitability

The supplied profile is presented for consideration under the Innovative Research Award associated with the Global Diseases Research Awards. Its subject alignment with non-communicable diseases and the reported scholarly indicators provide relevant contextual information for an academic recognition profile. Final award assessment should remain dependent on the applicable nomination, review, and judging criteria.[2]

Conclusion

Tarek El-Metwally’s supplied academic profile documents research activity associated with Al Jouf University and non-communicable diseases. The reported 45 documents, 847 citations, and h-index of 16 provide measurable indicators of indexed scholarly activity. The Innovative Research Award profile summarizes these indicators within the Global Diseases Research Awards framework..[5]

References

  1. Elsevier. (n.d.). Scopus author details: Tarek El-Metwally, Author ID 6507910852. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=6507910852
  2. Global Diseases Research Awards. (n.d.). Global Diseases Research Awards.
    https://globaldiseases.org/
  3. Othman, E. E. D. R., Hornung, D., Salem, H. T., Khalifa, E. A., El-Metwally, T. H., & Al-Hendy, A. (2008). Serum cytokines as biomarkers for nonsurgical prediction of endometriosis. European Journal of Obstetrics & Gynecology and Reproductive Biology, 137(2), 240–246.
    https://doi.org/10.1016/j.ejogrb.2007.05.001
  4. Ding, X.-Z., Kuszynski, C. A., El-Metwally, T. H., & Adrian, T. E. (1999). Lipoxygenase inhibition induced apoptosis, morphological changes, and carbonic anhydrase expression in human pancreatic cancer cells. Biochemical and Biophysical Research Communications, 266(2), 392–399.
    https://doi.org/10.1006/bbrc.1999.1824
  5. Ragab, S. M. M., Abd Elghaffar, S. K., El-Metwally, T. H., Badr, G., Mahmoud, M. H., & Omar, H. M. (2015). Effect of a high fat, high sucrose diet on the promotion of non-alcoholic fatty liver disease in male rats: The ameliorative role of three natural compounds. Lipids in Health and Disease, 14, 83. https://doi.org/10.1186/s12944-015-0087-1 

Olawunmi Oyedeji | Oncology | Innovative Research Award

Innovative Research Award

Olawunmi Oyedeji
The Christie NHS Foundation Trust

                          Olawunmi Oyedeji
Affiliation The Christie NHS Foundation Trust
Country United Kingdom
Scopus ID 58803277000
Documents 2
Citations 2
h-index 2
Subject Area Oncology
Event Global Diseases Research Awards
ORCID 0009-0008-0626-3422

Olawunmi Oyedeji is a researcher affiliated with The Christie NHS Foundation Trust, United Kingdom, whose academic activities contribute to the field of oncology research. The Innovative Research Award recognizes researchers demonstrating valuable contributions through scientific investigation, clinical advancement, and knowledge development within their respective disciplines. [1]

Abstract

The Innovative Research Award highlights academic excellence and meaningful contributions in oncology research. Olawunmi Oyedeji, affiliated with The Christie NHS Foundation Trust, United Kingdom, represents emerging research activities focused on advancing healthcare knowledge and improving scientific understanding. With documented publications, citations, and research engagement indexed through Scopus, the researcher demonstrates participation in scholarly communication. The award recognizes dedication toward innovative approaches, evidence-based practices, and contributions supporting progress in global disease research and clinical advancement. [1]

Keywords

Oncology Research, Clinical Research, Innovative Research Award, Cancer Research, Healthcare Innovation

Introduction

Oncology research plays an important role in understanding cancer biology, improving diagnosis, and developing effective therapeutic strategies. Researchers working within clinical and academic institutions contribute essential evidence that supports improvements in patient care and healthcare systems. [2]

Research Profile

Olawunmi Oyedeji is associated with The Christie NHS Foundation Trust, a leading healthcare institution in the United Kingdom. The research profile includes two indexed documents, two citations, and an h-index of two according to available Scopus information. [1]

Research Contributions

The researcher’s contributions are positioned within oncology and healthcare research. Scientific contributions in this area support better understanding of diseases, treatment approaches, clinical methodologies, and evidence-based medical practices. Such efforts strengthen collaborative research environments and promote advancement in cancer-related knowledge. [2]

Publications

The researcher has published scholarly documents indexed within Scopus databases. These publications contribute to academic discussions in oncology and related healthcare disciplines. Research outputs provide opportunities for knowledge exchange and future scientific collaboration among international researchers. [3]

Research Impact

Research impact is reflected through scholarly visibility, citation activity, and contribution to scientific literature. The available metrics indicate participation in academic research communication and demonstrate the importance of continued investigation within oncology and clinical sciences. [4]

Award Suitability

The Innovative Research Award recognizes researchers who demonstrate commitment toward scientific advancement and meaningful research activities. Based on the researcher’s oncology-focused profile, institutional affiliation, and academic contributions, Olawunmi Oyedeji represents a suitable candidate for recognition within the Global Diseases Research Awards framework. [4]

Conclusion

Olawunmi Oyedeji’s research profile demonstrates involvement in oncology-related scientific activities through institutional association, publications, and academic indexing. The Innovative Research Award acknowledges continued efforts toward research development and contributions supporting healthcare innovation and global scientific progress.

External Links

References

  1. Elsevier. (n.d.). Scopus author details: Olawunmi Oyedeji, Author ID 58803277000. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=58803277000
  2. Global Diseases Research Awards. (n.d.). Innovative Research Award Information.
    https://globaldiseases.org/
  3. Oisakede, E. O., Oyedeji, O. O., Olawuyi, O. F., Alabi, J. O., Daniel, R. I. A., & Olawade, D. B. (2026). Nanoparticle-mediated cardiotoxicity and nanomedicine interventions in cancer treatment. Nano TransMed, 5, Article 100113.
    https://doi.org/10.1016/j.ntm.2026.100113
  4. Oyedeji, O. O., & Oisakede, E. O. (2026). Radiation-induced rhinosinusitis after treatment of nasopharyngeal and selected sinonasal cancers: A narrative review. Sinusitis, 10(1), Article 100015.
    https://doi.org/10.3390/sinusitis10010015

Nazlı Erdoğdu | Cancer | Research Excellence Award

Assoc. Prof. Dr. Nazlı Erdoğdu | Cancer | Research Excellence Award

Hacettepe University | Turkey

Assoc. Prof. Dr. Nazlı Erdoğdu is an academic researcher at Hacettepe University, Ankara, Turkey, with recognized expertise in pharmaceutical nanotechnology, dermal and transdermal drug delivery systems, and advanced topical formulations. Her research focuses on the design and evaluation of nanoparticle-based delivery platforms, including polymeric nanoparticles and chitosan-based systems, aimed at improving therapeutic efficacy and safety for dermatological and oncological applications. She has authored 23 Scopus-indexed publications, which have received over 538 citations, reflecting the relevance and impact of her work within the scientific community, and holds an h-index of 12. Dr. Erdoğdu has collaborated with a broad network of 40 international and national co-authors, contributing to interdisciplinary research efforts. Her work supports translational pharmaceutical research with potential societal impact in improving targeted, patient-friendly therapies.

Citation Metrics (Scopus Preview)

538
400
300
150
0

Citations

538

Documents

23

h-index

12

Citations

Documents

h-index

View Scopus Profile
               View ORCID Profile

Top 5 Featured Publications